Infection with the hepatitis B virus (HBV) is one of the most common types of hepatitis worldwide. Chronic hepatitis B can lead to cirrhosis (scarring and dysfunction of the liver), liver cancer, liver failure, and death. NewYork-Presbyterian’s liver specialists are experts in the care of people with hepatitis B, offering the latest medications and monitoring techniques. Our doctors led and participated in major clinical trials that led to the development of the standard viral hepatitis therapies used today, as well as those evaluating investigational treatments. We offer liver transplantation for people whose hepatitis B becomes life-threatening, and we have more clinical experience caring for these people than most hospitals.

A Team of Hepatitis B Professionals

Chronic hepatitis B requires a lifetime of treatment and monitoring. We assemble the team of liver care experts that you need, including hepatologists (liver doctors), gastroenterologists, surgeons, physician assistants, nurses, social workers, and others with experience treating HBV and other liver disorders. All of the healthcare providers you may need are available to you, in one medical center.

Hepatitis B Prevention and Treatment

If you are at risk for hepatitis B, there is a vaccine you can receive to prevent it. Hepatitis B may require therapy with antiviral medications such as entecavir or tenofovir. The drugs used today to treat HBV are targeted therapies that work by slowing the ability of the virus to multiply.

Your team will also assess you periodically to determine if your disease is getting worse and see if you have liver damage, and tailor your care appropriately.

Surveillance to Detect Liver Cancer Early

The most common causes of primary liver cancer are chronic infection with the hepatitis B and C viruses, excessive alcohol consumption, and fatty liver disease. NewYork-Presbyterian has a strong surveillance program for people at risk of liver cancer, particularly those with chronic hepatitis B or hepatitis C, with the hope of detecting the disease in its early, more curable stages.

Liver Transplantation for Hepatitis B Infection

If you have hepatitis B infection that significantly impairs your liver function and becomes life-threatening, you may be eligible for a liver transplant. At NewYork-Presbyterian, you are ten times more likely to receive a liver transplant than at other hospitals in the region, with an average wait time of just nine months. Our surgeons have performed more than 2,000 liver transplants, with outcomes that meet or surpass national averages. They use a variety of liver transplant approaches, including living donor liver transplantation, to extend the limits of organ transplantation and provide the greatest number of transplants possible.

Clinical Trials for Hepatitis B

NewYork-Presbyterian investigators continue to lead studies of new treatments for HBV. You may have the opportunity to participate in a clinical trial of an innovative and promising therapy.

Contact Us

Center for Liver Disease & Transplantation

NewYork-Presbyterian/Columbia University Irving Medical Center

Gastroenterology & Hepatology

NewYork-Presbyterian/Weill Cornell Medical Center